La chaîne d'options affiche les données clés des options sur actions de S&W Seed à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour S&W Seed..

S&W Seed (NASDAQ:SANW) Stock, Chaîne d'Options

S&W Seed

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Shineco Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>)</h3>
<ul class="wp-block-list">
<li>On June 2, Shineco announced that it will raised $13.5 million through the sale of 18 million common shares at $0.75 each to non-US investors. The company's stock fell around 64% over the past month and has a 52-week low of $0.15.</li>
<li>RSI Value: 28</li>
<li>SISI Price Action: Shares of Shineco gained 6.9% to close at $0.17 on Tuesday.</li>
<li>Edge Stock Ratings: 91.92 Momentum score with Value at 93.51.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/SISI"><img loading="lazy" decoding="async" width="432" height="186" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010720/image-89.png" alt="" class="wp-image-977590" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010720/image-89.png 432w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010720/image-89-300x129.png 300w" sizes="(max-width: 432px) 100vw, 432px" /></a></figure>
<h3 class="wp-block-heading">S&amp;W Seed Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>)</h3>
<ul class="wp-block-list">
<li>On May 15, S&amp;W Seed posted upbeat quarterly results and lowered its FY2025 sales guidance. &#8220;The strategic actions we have taken during the past year to reposition S&amp;W&#8217;s focus on our high-value, high-margin sorghum trait technology were clearly beginning to deliver results during the most recent third quarter (January through March 2025) culminating in year-over-year revenue growth, strong improvement in gross margins, and our first positive Adjusted EBITDA quarter in many years,&#8221; commented Mark Herrmann, CEO of S&amp;W Seed Company. The company's stock fell around 62% over the past month and <a href="https://www.benzinga.com/quote/SANW">has a 52-week low </a>of $1.98.</li>
<li>RSI Value: 21.4</li>
<li>SANW Price Action: Shares of S&amp;W Seed gained 2.6% to close at $2.14 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0709">SANW stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0709"><img loading="lazy" decoding="async" width="925" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010837/image-90.png" alt="" class="wp-image-977592" style="width:629px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010837/image-90.png 925w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010837/image-90-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09010837/image-90-768x706.png 768w" sizes="(max-width: 925px) 100vw, 925px" /></a></figure>
<h3 class="wp-block-heading">22nd Century Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>)</h3>
<ul class="wp-block-list">
<li>On June 24, 22nd Century announced updates to Pinnacle product manufacturing and marketing agreement with top-5 C-store chain customer. The company's stock fell around 65% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/XXII">low of $5.73.</a></li>
<li>RSI Value: 18.8</li>
<li>XXII Ltd Price Action: Shares of 22nd Century Group fell 5.1% to close at $5.92 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0709">XXII shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0709"><img loading="lazy" decoding="async" width="911" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09011347/image-91.png" alt="" class="wp-image-977600" style="width:674px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09011347/image-91.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09011347/image-91-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/09011347/image-91-768x717.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
BZ Edge Rankings: Find out where other stocks stand—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">explore the full comparison now</a>.
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46296650/top-2-industrials-stocks-you-may-want-to-dump-this-quarter">Top 2 Industrials Stocks You May Want To Dump This Quarter</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

SANW

SISI

XXII

Top 3 Risk Off Stocks That May Rocket Higher In Q3

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 200 points on Monday.
Following the market opening Monday, the Dow traded up 0.50% to 42,417.90 while the NASDAQ gained 0.61% to 19,566.92. The S&amp;P 500 also rose, gaining, 0.62% to 6,004.66.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45993572/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Industrials Stocks That May Fall Off A Cliff In Q2</a>
Leading and Lagging Sectors Consumer discretionary shares jumped by 1.7% on Monday.
In trading on Friday, energy stocks fell by 0.1%.
Top Headline
Shares of FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) gained around 5% on Monday after the company posted results for the third quarter.
The company reported quarterly sales of $585.52 million, surpassing analyst expectations of $580.50 million and representing a 5.9% year-over-year gain.
The company reported quarterly adjusted earnings per share of $4.27, missing the street view of $4.29.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Impact BioMedical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBO#NYSE">IBO</a>) shares shot up 306% to $1.5001. Dr Ashleys Limited and Impact BioMedical Inc. announced a strategic merger.</li>
<li>Shares of Indaptus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) got a boost, surging 139% to $0.6464 after tumbling 18% on Friday.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) shares were also up, gaining 91% to $40.08 after the company announced positive topline results from its Phase 2b NAVIGATE trial evaluating CD388, a non-vaccine preventative of seasonal influenza.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>S&amp;W Seed Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) shares dropped 50% to $2.6741.</li>
<li>Shares of Lipella Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) were down 32% to $1.13. Lipella Pharmaceuticals announced delisting from Nasdaq Capital Market.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) was down, falling 47% to $2.44. The company announced it reached its primary endpoint in the ongoing Phase 3 COMP005 trial.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $72.94 while gold traded up 0.3% at $3,397.20.
Silver traded up 0.6% to $36.235 on Monday, while copper rose 0.3% to $4.8495.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.3%, while Spain's IBEX 35 Index rose 0.2%. London's FTSE 100 slipped 0.2%, Germany's DAX 40 declined 0.2% and France's CAC 40 fell 0.6% during the session.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei falling 0.13%, Hong Kong's Hang Seng Index gaining 0.67%, China's Shanghai Composite rising 0.65% and India's BSE Sensex falling 0.62%.
Economics
<ul class="wp-block-list">
<li>The S&amp;P Global US services PMI fell to 53.1 in June versus 53.7 in the previous month, and compared to market expectations of 52.9.</li>
<li>The S&amp;P Global US manufacturing PMI came in unchanged from the previous month at 52 in June.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46051985/amd-to-rally-more-than-36-here-are-10-top-analyst-forecasts-for-monday">AMD To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

CDTX

CMPS

INDP

LIPO

Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results

Lake Street analyst Ben Klieve maintains S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) with a Buy and lowers the price target from $35 to $25.

Price Target

Analyst Ratings

Lake Street Maintains Buy on S&W Seed, Lowers Price Target to $25

Fiscal 2025 Guidance
The Company is updating its expectations for fiscal 2025 revenue to be in the range of $29.0 to $31.0 million. The change in expectations is primarily due to expected continuing disruptions within the U.S. sorghum market due to decreased exports by customers to China and general market uncertainty. In fiscal 2024, comparable revenue from continuing operations was $38.0 million, which excludes revenue generated by the Company's former Australian subsidiary.&nbsp;
The Company now expects Adjusted EBITDA to be in the range of ($8.5) to ($7.0) million for fiscal 2025.

Guidance

S&W Seed Lowers FY2025 Sales Guidance from $34.50M-$38.00M to $29.00M-$31.00M vs $35.89M Est

S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.09) by 47.71 percent. This is a 68.16 percent increase over losses of $(1.79) per share from the same period last year. The company reported quarterly sales of $9.55 million which beat the analyst consensus estimate of $9.50 million by 0.53 percent. This is a 1.95 percent increase over sales of $9.37 million the same period last year.

Earnings

Earnings Beats

S&W Seed Q3 Adj. EPS $(0.57) Beats $(1.09) Estimate, Sales $9.55M Beat $9.50M Estimate

ACOG

AENT

AIRI

AMAT

AREN

BABA

BCLI

BEKE

BFRI

BHST

BIRK

BLIN

BNZI

BRAG

BTBT

BTDR

CAVA

CSIQ

CYCC

DFLI

DOCS

DTIL

DTST

DUOT

EDAP

EDBL

FLNT

FTLF

GAMB

GAME

GLOB

GORV

GOSS

GSX Techedu Inc. American Depositary Shares

GOTU

HAFN

IMCC

INKT

IVVD

JAGX

KORE

KPLT

KULR

LFWD

LGCY

LMFA

LPTH

LTRN

MITQ

MRSN

NICE

NRXP

NTES

NVVE

NXPL

OMER

ONDS

ORGN

PAVM

PHGE

PIII

PLBY

POCI

PPSI

PVLA

QUBT

RIME

RNXT

ROLR

SCWO

SIDU

SNYR

SOBO

SPCE

SRTS

SRXH

SWKH

TIVC

TLSI

TRAK

TSHA

TSSI

Earnings Scheduled For May 15, 2025

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">S&amp;W Seed Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>)</h3>
<ul>
<li>On Feb. 13, S&amp;W Seed reported worse-than-expected second-quarter financial results. &#8220;Over the past few months, we have completed a number of important steps to reposition S&amp;W for future success by exclusively focusing our operations on our core, Americas-based business, led by our high margin Double Team sorghum solutions,&#8221; commented S&amp;W&#8217;s CEO, Mark Herrmann. The company's stock fell around 43% over the past month and has a 52-week low of $2.11.</li>
<li>RSI Value: 27</li>
<li>SANW Price Action: Shares of S&amp;W Seed fell 3.7% to close at $4.58 on Tuesday.</li>
<li>Edge Stock Ratings: 99.73 Momentum score with Value at 82.82.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/SANW"><img loading="lazy" decoding="async" width="482" height="182" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080600/image-130.png" alt="" class="wp-image-883993" style="width:336px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080600/image-130.png 482w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080600/image-130-300x113.png 300w" sizes="(max-width: 482px) 100vw, 482px" /></a></figure>
<h3 class="wp-block-heading">Beeline Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNE#NASDAQ">BLNE</a>)&nbsp;&nbsp;</h3>
<ul>
<li>On April 15, Beeline Holdings reported a year-over-year decrease in FY24 revenue results. &#8220;Our 2024 performance is a testament to the strength of our model and the speed of our transformation,&#8221; said Nick Liuzza, Co-Founder and CEO of Beeline. The company's stock fell around 18% over the past month and<a href="https://www.benzinga.com/quote/BLNE"> has a 52-week low</a> of $0.89.</li>
<li>RSI Value: 22.2</li>
<li>BLNE Price Action: Shares of Beeline Holdings gained 17.1% to close at $1.37 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0423">BLNE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0423"><img loading="lazy" decoding="async" width="922" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080700/image-131.png" alt="" class="wp-image-883995" style="width:511px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080700/image-131.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080700/image-131-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080700/image-131-768x701.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">22nd Century Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>)</h3>
<ul>
<li>On April 17, 22nd Century announced notice of pendency and proposed settlement of stockholder derivative actions. The company's stock fell around 56% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/XXII"> low of $0.70</a>.</li>
<li>RSI Value: 21.5</li>
<li>XXII Price Action: Shares of 22nd Century closed at $0.76 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0423">XXII shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0423"><img loading="lazy" decoding="async" width="882" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080745/image-1-23.png" alt="" class="wp-image-883999" style="width:545px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080745/image-1-23.png 882w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080745/image-1-23-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23080745/image-1-23-768x729.png 768w" sizes="(max-width: 882px) 100vw, 882px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44920101/top-2-tech-and-telecom-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech And Telecom Stocks You May Want To Dump This Quarter</a> </li>
</ul>
Photo via Shutterstock

BLNE

Top 3 Risk Off Stocks That Are Set To Fly In Q2

WIIM

S&W Seed shares are trading lower after the company reported worse-than-expected Q2 financial results

S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) reported quarterly losses of $(2.05) per share which missed the analyst consensus estimate of $(0.09) by 2177.78 percent. This is a 1476.92 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $5.08 million which missed the analyst consensus estimate of $6.50 million by 21.89 percent. This is a 38.54 percent decrease over sales of $8.26 million the same period last year.

S&W Seed Q2 Adj EPS $(2.05) Misses $(0.09) Estimate, Sales $5.08M Miss $6.50M Estimate

ABNB

AGIO

ALNY

APDN

ATUS

AVNT

BENF

BFAM

BPMC

BRKR

BTOC

CBRE

CEVA

CLBT

CNVS

COHU

COIN

CROX

CYBR

DDOG

DKNG

DNOW

DXCM

EEFT

EGAN

ELME

ELVA

FBRT

FROG

GDDY

GEHC

GPMT

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIMX

HOUS

HTGC

IMPP

INFA

IRDM

IRMD

ISSC

KELYA

KELYB

KNSL

LECO

NTWK

NVMI

Earnings Scheduled For February 13, 2025

President Joe Biden prioritized <a href="https://www.benzinga.com/markets/cannabis/25/01/43054504/biden-commutes-sentences-of-nearly-2500-convicted-of-non-violent-drug-offenses-no-mention-of-cannabis-prisoners">freeing non-violent drug offenders</a> during his final few days in the White House, but TikTok? That's President-elect Donald Trump's problem now. 
According to the <a href="https://apnews.com/article/tiktok-ban-trump-executive-order-1e95d9836bf6f8c0c245ed1c3234d968">Associated Press</a>, Biden has no intention of enforcing the ban, which takes effect on his last full day in office, Jan. 19, and one day <a href="https://www.benzinga.com/news/25/01/42995328/trump-inauguration-from-elon-musk-jeff-bezos-to-barack-obama-george-bush-and-bill-clinton-who-all-will-attend">before Trump&#8217;s inauguration</a>.
With a deadline looming, the app's fate lands in the hands of the so-called People's Bid for TikTok—backed by none other than Kevin O'Leary of &#8220;Shark Tank&#8221; and billionaire Frank McCourt. Apparently, TikTok's U.S. assets are still up for grabs, but no word yet on the price tag or whether a deal can realistically get done <a href="https://www.benzinga.com/general/social-media/25/01/43060894/supreme-court-upholds-tiktok-ban-ahead-of-trumps-inauguration">in a few days</a>.
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Joann Inc. is stitching together a bankruptcy plan for the second time within 12 months. The Ohio-based fabric and crafts retailer is seeking a buyer for its portfolio of some 800 stores. 
Gordon Brothers Retail Partners emerged as the &#8220;stalking horse&#8221; bidder, but Joann remains hopeful for better offers—perhaps from someone who knows how to thread the needle.
Previously, the 82-year-old retailer was under the stewardship of private equity firm Leonard Green &amp; Partners, which acquired it via a $1.6 billion leveraged buyout in 2011. The firm buried the company under a pile of debt (<a href="https://wolfstreet.com/2024/03/18/brick-and-mortar-meltdown-fells-another-retailer-joann-inc-files-for-bankruptcy-3-years-after-ipo/">reportedly</a> $921 million in long-term debt as of Oct. 31, 2020) and <a href="https://www.benzinga.com/news/21/03/20048728/ipo-preview-roblox-coupang-joann-lead-busy-week-of-offerings">sent it public in 2021</a>. 
Joann went private again in <a href="https://apnews.com/article/joann-bankruptcy-chapter-11-filing-75093d4032907c59a45e472dd4e23229">March</a> 2024 while under Chapter 11 bankruptcy protection. The company managed to reduce its $1 billion total debt by about $500 million at the time.
Despite efforts to save itself last year, Joann is joining the growing quilt of recent retail casualties: Party City, Big Lots, LL Flooring, The Body Shop and The Container Store <a href="https://www.benzinga.com/news/legal/24/12/42710619/deal-dispatch-party-city-wraps-big-lots-goes-bust-container-store-continues">to name a few</a>.
Kirkland &amp; Ellis is handling legal matters, while Centerview Partners LLC offers financial advice. Alvarez &amp; Marsal North America, LLC is overseeing the restructuring process.
<h2 class="wp-block-heading">New On The Block</h2>
<ul>
<li>Investment firm KKR &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) hired Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) to run an auction for its minority stake in Philippine fintech company Maya, Reuters reported. </li>
<li>New York-headquartered KKR owns more than 20% of Maya and the potential sale, if it goes through, could value Maya at more than $2 billion, one of the sources said.</li>
<li>DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is looking to <a href="https://www.benzinga.com/news/large-cap/25/01/43028181/chemical-company-dupont-electronics-business-separation-retains-water-business">jettison its electronics business</a>. The Wilmington, Delaware-based company expects the transaction to be completed by Nov. 1. DuPont also decided to retain its water business after evaluating strategic alternatives.</li>
<li>Ingevity Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVT#NYSE">NGVT</a>) is shopping its Performance Chemicals Industrial Specialties segment, which includes divesting parts of its North Charleston, South Carolina site. The company hopes to improve earnings cash flow and conclude the review process by year-end. Whether a transaction comes about <a href="https://www.benzinga.com/news/25/01/43027745/ingevity-explores-strategic-options-for-performance-chemicals-segment-to-strengthen-portfolio-projects-fy24-revenue-at-1-40-billion">remains to be seen</a>. </li>
<li>S&amp;W Seed Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) is up for sale. It&#8217;s also considering a merger or recapitalization as part of a larger strategic review. The Longmont, Colorado-based company has already sold its Australia subsidiary. &#8220;We continue to support all initiatives that optimize shareholder value and will consider the full range of potential strategic alternatives to ensure S&amp;W Seed is best positioned for future success,&#8221; chairman Alan Willits said.</li>
</ul>
See Also: <a href="https://www.benzinga.com/25/01/43046722/starship-explodes-during-flight-test-elon-musk-says-success-is-uncertain-but-entertainment-is-guaranteed">Starship Explodes During Flight Test, Elon Musk Says: &#8216;Success Is Uncertain, But Entertainment Is Guaranteed!&#8217;</a>
<h2 class="wp-block-heading">Updates From The Block</h2>
<ul>
<li>Lourenco Goncalves raised eyebrows during a Monday press conference. According to <a href="https://www.bloomberg.com/news/articles/2025-01-14/cliffs-ceo-rips-evil-japan-and-doubles-down-on-america-first">Bloomberg</a>, the CEO of Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) called Japan, a U.S. ally, &#8220;evil&#8221; and accused it of teaching China harmful practices like dumping and overproduction. His comments came as Cleveland-Cliffs eyes a new bid for U.S. Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), following Biden&#8217;s decision to block Nippon Steel&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NPSCY#OTC">NPSCY</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42787508/biden-blocks-14-9b-us-steel-takeover-shares-plunge">$14 billion acquisition attempt</a>. While positioning his company as a potential buyer, Goncalves&#8217; rhetoric escalated tensions within the steel industry. Nippon is now looking to Trump to <a href="https://www.benzinga.com/news/25/01/42994950/nippon-steel-eyes-trump-administration-to-revive-15b-us-steel-deal-blocked-by-biden-well-do-whatever-it-takes">help close the deal</a>. </li>
<li>T-Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) will buy Vistar Media for $600 million. The telecom company expects the deal to strengthen its advertising business, Reuters reported. </li>
</ul>
Deals in the biotech and pharmaceutical sectors piled up this week. Here&#8217;s a sample of Benzinga&#8217;s coverage:
<ul>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) submitted an unsolicited bid to acquire all of the outstanding shares of Sage Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) that it does not already own <a href="https://www.benzinga.com/25/01/42957657/biogens-push-for-sage-therapeutics-could-strengthen-its-neurology-strategy-analysts-say">for $7.22 per share</a>. Goldman Sachs analyst Salveen Richter believes the proposal makes strategic sense, considering the financial success of the Zurzuvae launch for postpartum depression (PPD).</li>
<li>GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) <a href="https://www.benzinga.com/25/01/42950025/gsk-to-buy-us-based-stomach-cancer-drug-developer-for-over-1-billion">agreed to acquire</a> IDRx, Inc., a biopharmaceutical company focused on precision therapeutics for gastrointestinal stromal tumors (GIST), for $1 billion. The deal may require an additional $150 million from GSK after certain regulatory approval milestones. </li>
<li>Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) scooped up Scorpion Therapeutics&#8217; early-stage <a href="https://www.benzinga.com/25/01/42949261/eli-lilly-scoops-up-scorpion-therapeutics-early-stage-cancer-program-for-25-billion">cancer program for $2.5 billion</a>. </li>
<li>Like Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) and AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) is seeking to bolster its neuropsychiatric portfolio<a href="https://www.benzinga.com/general/biotech/25/01/42948170/like-bristol-myers-squibb-and-abbvie-johnson-johnson-seeks-to-bolster-neuropsychiatric-portfolio-with-15-billion-deal"> with a $15 billion deal</a></li>
<li>Crown Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) offered to acquire all outstanding common shares of Revance Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) at $3.10 per share.</li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) agreed to a deal with Decoy Therapeutics, a preclinical biotech focused on peptide conjugate therapeutics. The merged entity will target unmet needs in respiratory diseases and GI oncology.</li>
<li>Lantheus Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) strengthens its radiopharmaceutical position with<a href="https://www.benzinga.com/m-a/25/01/42937565/lantheus-strengthens-radiopharmaceutical-leadership-with-350m-acquisition-of-life-molecular-imaging"> $350 million acquisition of Life Molecular Imaging</a>.</li>
</ul>
For last week&#8217;s edition of Deal Dispatch, <a href="https://www.benzinga.com/ma/25/01/42921113/deal-dispatch-td-bank-charles-schwab-eyenovia-smart-share-hit-auction-block">click here</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/01/43055513/eccentric-billionaire-howard-hughes-former-miami-estate-on-market-for-55-5-million">Eccentric Billionaire, Legendary Filmmaker Howard Hughes&#8217; Former Miami Estate On Market For $55.5 Million</a></li>
</ul>
Image created with a photo from Shutterstock.

ABBV

BIIB

LNTH

NGVT

NPSCY

RVNC

SAGE

SLRX

TMUS

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

The Company expects to consider a broad range of potential opportunities, including, among others, a sale of the Company, a merger with another strategic partner, a recapitalization or continued execution of the Company's attractive long-term business plan.

S&W Seed Company Commences Process To Explore And Evaluate Various Strategic Alternatives

S&W Seed Expects High End Of Range To Be At Adjusted EBITDA Breakeven For The Rest Of FY25

S&W Files Q1 2025 10-Q; Says Financial Results Filed Are In Line With Preliminary Financial Results Previously Released

S&W Seed shares are trading higher after Lake Street maintained a Buy rating on the stock and raised its price target from $10 to $35.

Lake Street analyst Ben Klieve maintains S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) with a Buy and raises the price target from $10 to $35.

Lake Street Maintains Buy on S&W Seed, Raises Price Target to $35

S&W Seed shares are trading higher after the company announced it has finalized the voluntary plan of administration  process for its subsidiary, S&W Seed Company Australia.

As previously reported, S&amp;W Australia adopted a voluntary administration process on July 24, 2024, and on October 11, 2024 creditors of S&amp;W Australia approved a proposed Deed of Company Arrangement pursuant to which, among other things, 100% of the shares in S&amp;W Australia would be transferred to Avior Asset Management No. 3 Pty Ltd. The effective date of the DOCA is November 22, 2024.&nbsp;

S&W Seed Finalizes Voluntary Plan Of Administration Process For Subsidiary S&W Australia; On November 22, S&W Entered Settlement Agreement In Exchange For Release From Intercompany Obligations Owed To S&W Australia

S&W Seed shares are trading higher. The company preliminary Q1 financial results and issued FY25 guidance.

Fiscal 2025 Guidance
S&amp;W expects fiscal 2025 revenue to be within a range of $34.5 to $38 million. This includes approximately $4.1 million of international sales in the just completed first quarter of fiscal 2025. Adjusted EBITDA is expected to be in the range of ($5.0) million to ($3.0) million for fiscal 2025. Adjusted EBITDA for the first quarter of fiscal 2025 was ($3.1) million indicating that the Company expects adjusted EBITDA for the remaining three quarters of the fiscal year to be in a range of ($1.9) to $0.1 million.

S&W Seed 2025 Guidance: Expects Revenue Of $34.5M-$38M; Sees Adjusted EBITDA Of ($5.0)M-($3.0)M

Press Releases

S&W Seed Company to Report First Quarter Fiscal Year 2025 Financial Results on Tuesday, November 19, 2024

Comments

S&W Seed

S&W Seed (SANW) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL